Table 3.

The correlations between nuclear HuR expression and the clinical features of GC patients. P value < 0.05 was indicated in bold.

Variable	N	Nuclear HuR expression				P value
		HuR-high	%	HuR-low	%
Sex	251
Male	178	116	65.2	62	34.8	0.613
Female	73	50	68.5	23	31.5
Age
<60	80	49	61.2	31	38.8	0.263
≥60	171	117	68.4	54	31.6
Depth of invasion
T1-T3	82	47	57.3	35	42.7	0.040
T4	169	119	70.4	50	29.6
Lymph node metastasis
Absent (N0)	104	63	60.6	41	39.4	0.118
Present (N1-N3)	147	103	70.1	44	29.9
Distant metastasis
M0	226	146	64.6	80	35.4	0.123
M1	25	20	80.0	5	20
TNM Stage
1 + 2	116	67	57.8	49	42.2	0.009
3 + 4	135	99	73.3	36	26.7
Tumor size (cm)
>5	93	70	75.3	23	24.7	0.019
≤5	158	96	60.8	62	39.2
Differentiation status
Well/Moderate	147	95	64.6	52	35.4	0.548
Poor/Undifferentiated	104	71	68.3	33	31.7
TTP-expression
TTP-high	101	58	57.4	43	42.6	0.017
TTP-low	150	108	72.0	42	28.0
Cytoplasmic HuR
Positive	81	58	71.6	23	28.4	0.206
Negative	170	108	63.5	62	36.5